Evidence map›Paper›PMID 42568187›Full record

ArticleHGG advances2026

The AP5B1 p.Leu785Pro variant is a frequent cause of late-onset macular dystrophy with variable extraocular manifestations.

Petra Liskova, Lubica Dudakova, Karolina Kaminska, Laura Kühlewein, Stefanida Shliaga, Rina Leibu, Miriam Ehrenberg, Dinah Zur, Jana Zernant, Miriam Bauwens and 29 more

Abstract read
In one paragraph

Article in HGG advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Petra LiskovaDepartment of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic; Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic. Electronic address: petra.liskova@lf1.cuni.cz.
Lubica DudakovaDepartment of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic.
Karolina KaminskaInstitute of Molecular and Clinical Ophthalmology Basel (IOB), 4031 Basel, Switzerland; Department of Ophthalmology, University of Basel, 4031 Basel, Switzerland.
Laura KühleweinCentre for Ophthalmology, University Eye Hospital, University Hospital Tübingen, 72076 Tübingen, Germany.
Stefanida ShliagaDepartment of Human Genetics, Radboud University Medical Center, Nijmegen 6525 GA, the Netherlands.
Rina LeibuDepartment of Ophthalmology, Rambam Health Care Campus, Haifa 3109601, Israel.
Miriam EhrenbergDepartment of Ophthalmology, Schneider Children's Medical Center of Israel, Petah Tikva 4920235, Israel.
Dinah ZurDivision of Ophthalmology, Tel Aviv Sourasky University Medical Center, Tel Aviv 6423906, Israel; Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
Jana ZernantDepartment of Ophthalmology, Columbia University, New York, NY 10027, USA.
Miriam BauwensCenter for Medical Genetics, Ghent University Hospital, 9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
Gavin ArnoJC Self Research Institute, Greenwood Genetic Center, Greenwood, SC 29646, USA; UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK; National Institute of Health Research Biomedical Research Centre, Moorfields Eye Hospital, London EC1V 9EL, UK.
Isabelle MüllerEye Clinic, Luzerner Kantonsspital (LUKS), 6004 Luzern, Switzerland.
Focke ZiemssenDepartment of Ophthalmology, University of Leipzig, 04109 Leipzig, Germany.
Viktoria BotheInstitute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.
Francesca CancellieriInstitute of Molecular and Clinical Ophthalmology Basel (IOB), 4031 Basel, Switzerland; Department of Ophthalmology, University of Basel, 4031 Basel, Switzerland.
Julie De ZaeytijdDepartment of Ophthalmology, Ghent University Hospital, 9000 Ghent, Belgium.
Pascale MazzolaInstitute of Medical Genetics and Applied Genomics, University of Tübingen, 72076 Tübingen, Germany.
Winston LeeBascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Bohdan KousalDepartment of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic.
Marie VajterDepartment of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic; Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic.
L Ingeborgh van den BornThe Rotterdam Eye Hospital, Rotterdam 3011 BH, the Netherlands.
Anton SonntagCentre for Ophthalmology, University Eye Hospital, University Hospital Tübingen, 72076 Tübingen, Germany.
Yoeri van LeeuwenDepartment of Ophthalmology, Radboud University Medical Center, Nijmege 6525 GA, the Netherlands.
Dzenita SmailhodzicThe Rotterdam Eye Hospital, Rotterdam 3011 BH, the Netherlands.
Caroline C W KlaverInstitute of Molecular and Clinical Ophthalmology Basel (IOB), 4031 Basel, Switzerland; Department of Ophthalmology, Radboud University Medical Center, Nijmege 6525 GA, the Netherlands; Department of Ophthalmology, Erasmus Medical Center Rotterdam, Rotterdam 3015CE, the Netherlands; Department of Epidemiology, Erasmus Medical Center Rotterdam, Rotterdam 3015CE, the Netherlands.
Tobias B HaackInstitute of Medical Genetics and Applied Genomics, University of Tübingen, 72076 Tübingen, Germany; Centre for Rare Diseases, University of Tübingen, 72072 Tübingen, Germany.
Bernd WissingerInstitute for Ophthalmic Research, Center for Ophthalmology, University of Tübingen, 72076 Tübingen, Germany.
Andrew R WebsterUCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK; NIHR Biomedical Research Centre, Moorfields Eye Hospital, London EC1V 9EL, UK.
Lonneke Haer-WigmanDepartment of Human Genetics, Radboud University Medical Center, Nijmegen 6525 GA, the Netherlands.
Siying LinNational Institute of Health Research Biomedical Research Centre, Moorfields Eye Hospital, London EC1V 9EL, UK; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Saint Mary's Hospital, Manchester, UK; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.
Moreno MenghiniEye Clinic, Luzerner Kantonsspital (LUKS), 6004 Luzern, Switzerland; Ophthalmology Service, Institute of Clinical Neurosciences of Southern Switzerland (INSI), Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland; Faculty of Biomedical Sciences, University of Southern Switzerland (USI), Lugano, Switzerland.
Konrad PlatzerInstitute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.
Elfride De BaereCenter for Medical Genetics, Ghent University Hospital, 9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
Rando AllikmetsDepartment of Ophthalmology, Columbia University, New York, NY 10027, USA; Department of Pathology & Cell Biology, Columbia University, New York, NY 10027, USA.
Carlo RivoltaInstitute of Molecular and Clinical Ophthalmology Basel (IOB), 4031 Basel, Switzerland; Department of Ophthalmology, University of Basel, 4031 Basel, Switzerland; Department of Genetics and Genome Biology, University of Leicester, Leicester LE1 7RH, UK.
Susanne RoosingDepartment of Human Genetics, Radboud University Medical Center, Nijmegen 6525 GA, the Netherlands.
Susanne KohlInstitute for Ophthalmic Research, Center for Ophthalmology, University of Tübingen, 72076 Tübingen, Germany.
Tamar Ben-YosefThe Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel.
Mathieu QuinodozInstitute of Molecular and Clinical Ophthalmology Basel (IOB), 4031 Basel, Switzerland; Department of Ophthalmology, University of Basel, 4031 Basel, Switzerland; Department of Genetics and Genome Biology, University of Leicester, Leicester LE1 7RH, UK. Electronic address: mathieu.quinodoz@iob.ch.

Funding

Instrumentation, Fabrication, and Design CoreP30EY019007 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Xin Zhang · 2010 to 2026
$12.9M
Quantitative Fundus Autofluorescence in Retinal DisordersR01EY024091 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SPARROW, JANET RUTHE · 2014 to 2022
$3.4M
Precision medicine for ABCA4 disease: modifier allelesR01EY028203 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ALLIKMETS, RANDO L · 2018 to 2021
$2.3M
Integrated clinical, genetic and functional analysis of the ABCA4 locusR01EY029315 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ALLIKMETS, RANDO L · 2019 to 2023
$2.2M
Stargardt disease with low lipofuscinR01EY028954 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ALLIKMETS, RANDO L · 2019 to 2022
$2.1M
Stargardt/ABCA4 disease in African AmericansR01EY036061 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI RANDO L ALLIKMETS · 2024 to 2026
$1.8M
Structured quantification of inherited macular disease phenotypes as the basis for automated algorithms to determine causal genesK99EY036930 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Winston Lee · 2025 to 2026
$213k
NEI NIH HHS K99 EY036930NEI NIH HHS P30 EY019007NEI NIH HHS R01 EY024091NEI NIH HHS R01 EY028203NEI NIH HHS R01 EY028954NEI NIH HHS R01 EY029315NEI NIH HHS R01 EY036061
6 · The paper itself

Abstract

Inherited retinal diseases (IRDs) represent a large group of genetically heterogeneous disorders that often cause progressive visual loss. The fifth adaptor protein (AP-5) complex, which contributes to endolysosomal trafficking and lysosomal homeostasis, has previously been implicated in neurodegenerative syndromes, and more recently, bi-allelic variants in three of its subunits were found in families with macular dystrophy, including four with variants in AP5B1. Here, we describe 22 affected individuals from 20 families with AP5B1-associated IRD, all carrying the recurrent missense variant c.2354T>C (GenBank: NM_138368.5) (p.Leu785Pro), either in the homozygous state (16 families) or in trans with another rare heterozygous AP5B1 missense or loss-of-function variant. Five families were of Ashkenazi Jewish ancestry and 15 families of European ancestry. Clinically, affected individuals presented with a predominantly late-onset macular dystrophy that frequently progressed to cone-rod degeneration. Characteristic retinal findings included foveal sparing, early peripapillary involvement, and a reticular pattern best observed by fundus autofluorescence imaging in the mid- or peripheral retina. The typical presenting symptom was decreased visual acuity. Age at onset ranged from 27 to 74 years, with most individuals becoming symptomatic after the fifth decade of life. Some individuals also presented with extraocular manifestations, most notably hearing loss, which was reported in 8 affected individuals. These findings further support AP5B1 as a cause of macular dystrophy, identify p.Leu785Pro as a relatively frequent pathogenic allele in individuals of European and Ashkenazi Jewish ancestry, and expand the associated phenotypic spectrum to include both isolated macular dystrophy and possible syndromic presentations.

Indexed as

AP5B1cone-rod dystrophyfifth adaptor protein complexhearing lossinherited retinal diseasemacular dystrophy

Identifiers

PMID42568187
PMCPMC13524567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.